Page 46 - Biomarkers for risk stratification and guidance in heart failure
P. 46
CHAPTER 3
Management of chronic heart failure guided by individual N-Terminal pro–B-type natriuretic peptide targets
Results of the PRIMA study (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?)
Luc W. M. Eurlings, MD,1 Petra E. J. van Pol, MD,2 Wouter E. Kok, MD, PHD,3 Sandra van Wijk, MD,1 Cara Lodewijks-van der Bolt, MD,4 Aggie H. M. M. Balk, MD, PHD,5 Dirk J. A. Lok, MD, PHD,6 Harry J. G. M. Crijns, MD, PHD,1 Dave J. W. van Kraaij, MD, PHD,7 Nicolaas de Jonge, MD, PHD,8 Joan G. Meeder, MD, PHD,9 Martin Prins, MD, PHD,1 Yigal M. Pinto, MD, PHD3
(1) Maastricht University Medical Center, Maastricht, the Netherlands; (2) Reinier de Graaf Gasthuis, Delft, the Netherlands; (3) Academic Medical Center, Amsterdam, the Netherlands; (4) Atrium Medical Center, Heerlen, the Netherlands; (5) Erasmus University Medical Center, Rotterdam, the Netherlands; (6) Hospital Deventer, Deventer, the Netherlands; (7) Orbis Medical Center, Sittard, the Netherlands; (8) University Medical Center, Utrecht, the Netherlands; and (9) VieCuri Medical Center, Venlo.
Modified from Journal of the American College of Cardiology, 2010 Dec 14;56(25):2090-100
